Literature DB >> 19674020

Ethnic disparity in colonic cancer outcomes in New Zealand--biology or an access issue?

T Sammour1, A Kahokehr, R Vather, A B Connolly, A G Hill.   

Abstract

BACKGROUND: There is an ethnic variation in outcomes for colonic cancer in New Zealand. Whether this disparity is caused by cancer biology or inequitable provision of treatment services after diagnosis has not been elucidated.
METHOD: National cancer registry data from 1996 to 2003 were obtained. Incidence and mortality rates for the four major ethnic groups were age-adjusted to the new WHO world population. The impact of age, sex, AJCC stage and site of cancer at diagnosis was compared between ethnic groups using a Cox regression analysis.
RESULTS: A total of 11 987 colonic cancer registrations were identified. The overall raw 5-year mortality was 53.7%. The age-adjusted incidence in Europeans was more than double that of the Maori, Asian and Pacific populations at 33.0 per 100,000 population/year. Europeans presented at a greater age, with more right sided cancers, and at an earlier stage of disease. The opposite was true for the Maori population. Pacific Islanders and Asians presented at a younger age, but with a similar site, stage and sex distribution to the rest of the population. There were no significant differences in 5 year mortality after diagnosis when age, sex, stage, and site at presentation were controlled for by cox regression analysis.
CONCLUSION: These results suggest that age, sex, stage and site at presentation may be more important than inequality in treatment provision after diagnosis in explaining differences in outcomes between the ethnicities. Efforts need to be focused on identifying reasons for the increased risk of colonic neoplasia in Europeans and the later stage disease presentation in the Maori population.

Entities:  

Mesh:

Year:  2009        PMID: 19674020     DOI: 10.1111/j.1463-1318.2009.02028.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  4 in total

1.  Cohort Profile: The Christchurch IBS cOhort to investigate Mechanisms FOr gut Relief and improved Transit (COMFORT).

Authors:  Phoebe Heenan; Rob H Creemers; Shriya Sharma; Jacqueline Keenan; Simone Bayer; Wayne Young; Janine Cooney; Kelly Armstrong; Karl Fraser; Paula M Skidmore; Nicholas J Talley; Nicole Roy; Richard B Gearry
Journal:  Inflamm Intest Dis       Date:  2020-07-08

2.  A systematic review of methods to estimate colorectal cancer incidence using population-based cancer registries.

Authors:  Norah Alsadhan; Alaa Almaiman; Mar Pujades-Rodriguez; Cathy Brennan; Farag Shuweihdi; Sultana A Alhurishi; Robert M West
Journal:  BMC Med Res Methodol       Date:  2022-05-19       Impact factor: 4.612

Review 3.  Australia's national bowel cancer screening program: does it work for indigenous Australians?

Authors:  Aliki Christou; Judith M Katzenellenbogen; Sandra C Thompson
Journal:  BMC Public Health       Date:  2010-06-25       Impact factor: 3.295

4.  Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer.

Authors:  M Yi; J Xu; P Liu; G J Chang; X L Du; C-Y Hu; Y Song; J He; Y Ren; Y Wei; J Yang; K K Hunt; X Li
Journal:  Br J Cancer       Date:  2013-03-07       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.